White blood cells control final moments of their death

La Trobe University researchers have revealed for the first time how white blood cells control the final moments of their death, helping their own removal from the human body.

Scientists from the La Trobe Institute of Molecular Science (LIMS), working with renowned La Trobe cell biologist Associate Professor Ivan Poon, have identified a protein within dying cells called Plexin B2 that is responsible for coordinating a key stage of apoptosis (cell death).

Published today in Cell Reports, the study is a significant step forward in understanding what may trigger numerous disease states such as inflammation and autoimmunity.

Lead researcher Dr Georgia Atkin-Smith said the key function of Plexin B2 was discovered when they used CRISPR gene-editing technology to delete the protein from white blood cells.

Normally, dying white blood cells undergo a dynamic death and shoot out long, beaded, necklace-like structures and fragment into small pieces.

However, since our discovery of this process in 2015, we have not understood how or why this dance of death occurs.

Our new research identified the protein Plexin B2 as the first molecule which controls this event.

Lead researcher Dr Georgia Atkin-Smith

Dr Atkin-Smith said genetically deleting Plexin B2 prevented dying cells from forming beaded structures.

"Surprisingly, this defect in the cell death process significantly compromised their removal by the garbage trucks of the body, known as phagocytes," Dr Atkin-Smith said.

"Typically, dying cells send 'find me' and 'eat me' signals to phagocytes, however, deletion of Plexin B2 could limit the number of fragments that are 'ready-to-eat'."

This study follows research - published in June 2019 in Cell Death and Differentiation - from Associate Professor Poon and Dr Atkin-Smith, led by Dr Rochelle Tixeira, which also demonstrated the importance of dying cell fragmentation, through a process called blebbing, to aid in the efficient removal of cells by phagocytes.

Dr Atkin-Smith said understanding how dying cells are removed by phagocytes is fundamental.

"Defects in this process trigger a wide variety of inflammatory disorders like autoimmunity," Dr Atkin-Smith said.

"Now, for the first time, we have a new insight into what may be the underlining cause of these diseases."

Dr Atkin-Smith said, collectively, the researchers at Associate Professor Poon's laboratory are world-leaders in the science of dying cell fragmentation.

"Excitingly, the next phase of our research within Associate Professor Poon's laboratory is to take our key basic biology discoveries and examine them in pre-clinical models of autoimmunity," Dr Atkin-Smith said.

Background

This study follows earlier significant discoveries about cell death made by La Trobe University researchers.

The final moments of white blood cell death were discovered and recorded in 2015 by La Trobe cell biologists, Associate Professor Ivan Poon and Dr Georgia Atkin-Smith.

Associate Professor Poon and his research team at LIMS used time-lapse microscopy to capture the entire process of cell death, revealing the dynamic and coordinated nature of cell death they often refer to as 'the dance of death'.

Their research corrected a long-held scientific view that the breakdown of dying cells is a random process and revealed it is a controlled event with important functional significance.

Source:
Journal reference:

Atkin-Smith, G. K. et al. (2019) Plexin B2 Is a Regulator of Monocyte Apoptotic Cell Disassembly. Cell Reports. doi.org/10.1016/j.celrep.2019.10.014

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New CAR T-cell therapy shows promise against aggressive HER2+ breast cancer